ArticleThe Journal of clinical investigation2025

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.

Angela Schab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.